Prophylaxis of Hepatitis C with Intramuscular Immunoglobulin: Clinical and Economic Appraisal

ISSN： 1173-8804

Source： BioDrugs, Vol.12, Iss.4, 1999-10, pp. : 291-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Immunoglobulin Plus Interferon- in Autoimmune Hepatitis C

By Malaguarnera M.

BioDrugs, Vol. 18, Iss. 1, 2004-01 ,pp. : 63-70

Adis International

Access to resources Recommend Favorite

The Optimum Use of Intravenous Immunoglobulin for Prophylaxis of Opportunistic Infection in HIV-Infected Adults

By Kiehl M.G. Müller C.

BioDrugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 265-273

Adis International

Access to resources Recommend Favorite

Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use

By Chérin Patrick

BioDrugs, Vol. 24, Iss. 4, 2010-08 ,pp. : 211-223

Adis International

Access to resources Recommend Favorite

Development and Testing of the Clinical Research Appraisal Inventory-Short Form

By Eller Lucille Sanzero Lev Elise L. Bakken Lori L.

Journal of Nursing Measurement, Vol. 22, Iss. 1, 2014-04 ,pp. : 106-119

Springer Publishing Company

Access to resources Recommend Favorite

Development of Pegylated Interferons for the Treatment of Chronic Hepatitis C

By Kozlowski A. Charles S.A. Harris J.M.

BioDrugs, Vol. 15, Iss. 7, 2001-07 ,pp. : 419-429

Adis International

Access to resources Recommend Favorite